BioNTech and Pfizer have partnered to develop a COVID-19 vaccine candidate utilising messenger-RNA technology. Preliminary data has been announced this week, showing promising results.
Vaccine developers Pfizer and BioNTech have announced preliminary data shows their COVID-19 vaccine is demonstrating 90% effectiveness, with plans to apply for emergency approval to have the vaccine in use by the end of November.
Scientists will use social media platforms such as TikTok, Instagram and Twitter to communicate information about COVID-19 vaccines in development to rebuild public trust and combat misinformation.
New laws in the UK have been introduced to expand the workforce responsible for administering vaccines in an effort to improve access to vaccination.
Professor Jonathan Van-Tam, the deputy Chief Medical Officer for England, has warned that it is unlikely that any COVID-19 vaccine could be co-administered with influenza vaccines due to a lack of safety data.
In episode 16 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford speaks once again with Professor Norman Baylor. Professor Baylor is the former Director of the Office of Vaccines Research and Review Center at the U.S. Food and Drug Administration (FDA) and is the President and CEO of Biologics … Continued
Professor Kanta Subbarao suggests that community engagement and transparency will be key to the success of a COVID-19 vaccination campaign.